Rebound hypertension and acute withdrawal associated with discontinuation of an infusion of epidural clonidine

Anesthesiology

Volumn 84, Issue 3, 1996, Pages 729-731

  Fitzgibbon, Dermot R ^a   Rapp, Suzanne E ^a   Butler, Steven H ^a   Terman, Gregory W ^a   Dolack, G Lee ^a   DuPen, Stewart L ^a,b   Ready, L Brian ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

Author keywords

Anesthetic technique: epidural; Clonidine; Complications: rebound hypertension; withdrawal reaction; Pain: cancer

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ANALGESIA; ANESTHESIA MECHANISM; ARTICLE; CANCER PAIN; CASE REPORT; DRUG WITHDRAWAL; EPIDURAL ANESTHESIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INTRACTABLE PAIN; MALE; PRIORITY JOURNAL; ADENOCARCINOMA; MIDDLE AGED; PANCREAS TUMOR; PATHOPHYSIOLOGY; WITHDRAWAL SYNDROME;

ADENOCARCINOMA; ADRENERGIC ALPHA-AGONISTS; CLONIDINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PAIN, INTRACTABLE; PANCREATIC NEOPLASMS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029665785     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199603000-00031     Document Type: Article

References (24)

1. Cherny NI, Portenoy RK: Cancer pain management: Current strategy. Cancer 1993; 72:3393-415
2. Du Pen SL, Williams AR: Management of patients receiving combined epidural morphine and bupivacaine for the treatment of cancer pain. J Pain Symptom Manage 1992; 7:125-7
3. Hogan Q, Haddox JD, Abram S, Weissman D, Taylor ML, Janjan N: Epidural opiates and local anesthetics for the management of cancer pain. Pain 1991; 46:271-9
4. Meert TF, De Kock M: Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats. ANESTHESIOLOGY 1994; 81:677-88
5. Mogensen T, Eliasen K, Ejlersen E, Vegger P, Nielsen IK, Kehlet H: Epidural clonidine enhances postoperative analgesia from a combined low-dose epidural bupivacaine and morphine regimen. Anesth Analg 1992; 75:607-10
6. Ossipov MH, Suarez LJ, Spaulding TC: Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents. Anesth Analg 1989; 68:194-200
7. Sullivan AF, Dashwood MR, Dickenson AH: Alpha 2-adrenoceptor modulation of nociception in rat spinal cord: Location, effects and interactions with morphine. Eur J Pharmacol 1987; 138:169-77
8. Carabine UA, Milligan KR, Mulholland D, Moore J: Extradural clonidine infusions for analgesia after total hip replacement. Br J Anaesth 1992; 68:338-43
9. Bonnet F, Boico O, Rostaing S, Saada M, Loriferne JF, Touboul C, Abhay K, Ghignone M: Postoperative analgesia with extradural clonidine. Br J Anaesth 1989; 63:465-9
10. Eisenach J, Detweiler D, Hood D: Hemodynamic and analgesic actions of epidurally administered clonidine. ANESTHESIOLOGY 1993; 78:277-87
11. Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D: Epidural clonidine analgesia for intractable cancer pain. Pain 1995; 61:391-9
12. Weber MA: Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents. J Cardiovasc Pharmacol 1980; 2(suppl 1):73-89
13. Eisenach JC, Rauck RL, Buzzanell C, Lysak SZ: Epidural clonidine analgesia for intractable cancer pain: Phase I. ANESTHESIOLOGY 1989; 71:647-52
14. van Essen EJ, Bovill JG, Ploeger EJ, Beerman H: Intrathecal morphine and clonidine for control of intractable cancer pain: A case report. Acta Anaesthesiol Belg 1988; 39:109-12
15. Coombs DW, Saunders RL, Fratkin JD, Jensen LE, Murphy CA: Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. J Neurosurg 1986; 64:890-94
16. Guyenet PG, Cabot JB: Inhibition of sympathetic preganglionic neurons by catecholamines and clonidine: Mediation by an alpha-adrenergic receptor. J Neurosci 1981; 1:908-17
17. Jarrott B, Conway EL, Maccarrone C, Lewis SJ: Clonidine: Understanding its disposition, sites and mechanism of action. Clin Exp Pharmacol Physiol 1987; 14:471-9
18. Kiowski W, Hulth'en UL, Ritz R, Buhler FR: Prejunctional alpha 2-adrenoceptors and norepinephrine release in the forearm of normal humans. J Cardiovasc Pharmacol 1985; 7(suppl 6): 144-8
19. Ernsberger P, Giuliano R, Willette RN, Reis DJ: Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 1990; 253:408-18
20. Bousquet P, Feldman J, Bloch R, Schwartz J: The nucleus reticularis lateralis: A region highly sensitive to clonidine. Eur J Pharmacol 1981; 69:389-92
21. Svensson TH, Bunney BS, Aghajanian GK: Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 1975; 92:291-306
22. Hansson L, Hunyor SN, Julius S, Hoobler SW: Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J 1973; 85:605-10
23. Reid JL, Campbell BC, Hamilton CA: Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. Hypertension 1984; 6:71-5
24. Augustine SJ, Buckley JP, Tachikawa S, Lokhandwala MF: Involvement of central noradrenergic mechanisms in the rebound hypertension following clonidine withdrawal. J Cardiovasc Pharmacol 1982; 4:449-55